[1] |
Siegel RL, Miller KD, Jemal A . Cancer statistics, 2019[J]. CA A Cancer J Clin, 2019,69(1):7-34.
doi: 10.3322/caac.v69.1
URL
|
[2] |
Chinn SB, Myers JN . Oral cavity carcinoma: current management, controversies, and future directions[J]. J Clin Oncol, 2015,33(29):3269-3276.
doi: 10.1200/JCO.2015.61.2929
URL
pmid: 26351335
|
[3] |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会头颈部肿瘤诊疗指南2019[M]. 北京: 人民卫生出版社, 2019: 42.
|
|
Guidelines Working Committee of Chinese Society of Clinical Oncology. Guidelines of Chinese Society of Clinical Oncology (CSCO) Head and Neck Cancer 2019[M]. Beijing: People’s Medical Publishing House, 2019: 42.
|
[4] |
中华口腔医学会口腔颌面外科专业委员会肿瘤学组. 口腔颌面部恶性肿瘤治疗指南[J]. 中国口腔颌面外科杂志, 2010,8(2):98-106.
|
|
Division of Oral and Maxillofacial Oncology, Chinese Society of Oral and Maxillofacial Surgery . The protocol of treatment guideline of oral and maxillofacial malignant neoplasms[J]. Chin J Oral Maxillofac Surg, 2010,8(2):98-106.
|
[5] |
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines®) head and neck cancers (Version 2. 2020)[EB/OL]. [ 2020- 07- 15]. http://www.nccn.org .
|
[6] |
Kerawala C, Roques T, Jeannon JP , et al. Oral cavity and lip cancer: united kingdom national multidisciplinary guidelines[J]. J Laryngol Otol, 2016,130(S2):S83-S89.
doi: 10.1017/S0022215116000499
URL
pmid: 27841120
|
[7] |
Amin MB, Edge S, Greene F , et al. AJCC cancer staging manual[M]. 8th ed. Chicago: Springer, 2017: 79.
|
[8] |
D’Cruz AK, Vaish R, Kapre N , et al. Elective versus therapeutic neck dissection in node-negative oral cancer[J]. N Engl J Med, 2015,373(6):521-529.
doi: 10.1056/NEJMoa1506007
URL
pmid: 26027881
|
[9] |
Zhong LP, Zhang ZY . Reply to K. Devisetty et al[J]. J Clin Oncol, 2013,31(23):2972-2973.
doi: 10.1200/JCO.2013.50.4639
URL
pmid: 24079021
|
[10] |
Zhong LP, Zhang CP, Ren GX , et al. Randomized phase Ⅲ trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma[J]. J Clin Oncol, 2013,31(6):744-751.
doi: 10.1200/JCO.2012.43.8820
URL
|
[11] |
Spiotto MT, Jefferson G, Wenig B , et al. Differences in survival with surgery and postoperative radiotherapy compared with definitive chemoradiotherapy for oral cavity cancer: a national cancer database analysis[J]. JAMA Otolaryngol Head Neck Surg, 2017,143(7):691-699.
doi: 10.1001/jamaoto.2017.0012
URL
pmid: 28426848
|
[12] |
Ghi MG, Paccagnella A, Ferrari D , et al. Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase Ⅱ-Ⅲ trial[J]. Ann Oncol, 2017,28(9):2206-2212.
doi: 10.1093/annonc/mdx299
URL
pmid: 28911070
|
[13] |
Noronha V, Joshi A, Patil VM , et al. Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase Ⅲ randomized noninferiority trial[J]. J Clin Oncol, 2018,36(11):1064-1072.
doi: 10.1200/JCO.2017.74.9457
URL
pmid: 29220295
|
[14] |
Wang Z, Jiang L, Huang CH , et al. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma[J]. Mol Cell Proteomics, 2008,7(9):1639-1650.
doi: 10.1074/mcp.M700520-MCP200
URL
pmid: 18458027
|
[15] |
Santosh AB, Jones T, Harvey J . A review on oral cancer biomarkers: understanding the past and learning from the present[J]. J Cancer Res Ther, 2016,12(2):486-492.
doi: 10.4103/0973-1482.176414
URL
pmid: 27461598
|
[16] |
Zhong L, Liu YT, Wang K , et al. Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma[J]. BMC Cancer, 2018,18(1):911.
doi: 10.1186/s12885-018-4806-7
URL
pmid: 30241505
|
[17] |
Ju WT, Ma HL, Zhao TC , et al. Stathmin guides personalized therapy in oral squamous cell carcinoma[J]. Cancer Sci, 2020,111(4):1303-1313.
doi: 10.1111/cas.14323
URL
pmid: 31994271
|
[18] |
Andreassen CN, Eriksen JG, Jensen K , et al. IMRT-Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer[J]. Oral Oncol, 2018,86:91-99.
doi: 10.1016/j.oraloncology.2018.09.001
URL
pmid: 30409326
|
[19] |
Irimie AI, Braicu C, Cojocneanu-Petric R , et al. Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics[J]. Acta Odontol Scand, 2015,73(3):161-168.
doi: 10.3109/00016357.2014.986754
URL
pmid: 25598447
|
[20] |
Rai V, Mukherjee R, Ghosh AK , et al. “Omics” in oral cancer: new approaches for biomarker discovery[J]. Arch Oral Biol, 2018,87:15-34.
doi: 10.1016/j.archoralbio.2017.12.003
URL
pmid: 29247855
|